HON
- S&P 100 removal in September 2026 forced passive selling, creating near-term bearish pressure on HON.
- Aerospace division's reduced 2026 growth outlook and supply chain turmoil weigh on margins and revenue recognition.
- Susquehanna's Positive initiation and Quantinuum IPO success provide mid-term bullish catalysts.
- Long-term structural drivers like AI demand for Solstice chemicals and the quantum pivot support cautious optimism.
News situation · 1 items / 30 D
1 of 1 straight from the issuer or regulator
Honeywell is a study in contrasts right now. The most immediate and mechanical overhang is the September 2026 removal of Honeywell Aerospace from the S&P 100 index. That triggers forced selling by passive funds, a purely technical event that is likely to keep short-term sentiment pressured.
Read full analysis
This coincides with the aerospace unit slashing its 2026 growth forecast due to supply chain disruptions, a direct hit to margins and revenue visibility. On the other side of the ledger, several factors offer genuine support. Susquehanna initiated coverage with a Positive rating on attractive revenue growth and margin expansion potential, and the Quantinuum IPO raised $1.68 billion, marking up Honeywell's equity stake and validating its quantum computing strategy. The spinoff of HONA and the sale to Brady are smaller pieces, but they signal a deliberate portfolio reshaping. Longer-term, Honeywell's Solstice brand is positioned for a "generational opportunity" from AI-driven PFAS demand, which could be a structural growth engine. However, GE Aerospace's $12 billion acquisition of CPP, a key supplier, introduces a competitive wrench in the supply chain that could persist for years. The absence of technical signals means this assessment leans entirely on fundamentals, and the mixed directional drivers across horizons — bearish short-term, neutral mid-term, cautiously bullish long-term — reconcile into an overall neutral stance. Readers should weigh the forced selling overhang against the strategic catalysts and watch for announcements on supply chain resolutions or aerospace order updates.
Supporting factors
- Susquehanna initiated coverage with a Positive rating, citing attractive revenue growth and margin expansion potential.
- Quantinuum IPO raised $1.68 billion, boosting the value of Honeywell's equity stake and signaling quantum computing success.
- AI-driven demand for Solstice PFAS chemicals presents a generational opportunity for long-term growth.
- Ongoing portfolio reshaping via HONA spinoff and Brady sale may streamline focus and unlock value.
Risks and what to watch
- S&P 100 removal is triggering forced selling by passive funds, keeping near-term pressure and potentially testing recent lows.
- Aerospace supply chain disruptions and a cut 2026 growth forecast directly pressure margins and revenue recognition.
- GE Aerospace's $12 billion acquisition of CPP creates a long-term competitive threat to Honeywell's supply chain.
- Index exclusion and persistent supply chain issues may cap upside, limiting the stock's recovery potential.
How does the S&P 100 removal affect Honeywell's stock?
Honeywell Aerospace was removed from the S&P 100 index in September 2026. This means passive funds that track the index are forced to sell their Honeywell positions, creating selling pressure and contributing to bearish sentiment in the short term. Because this is a mechanical event, its impact is likely to fade once the forced selling is complete, but while it persists it can push the stock lower. The removal also signals a loss of status, which may affect investor perception. The effect is most pronounced over the near-term horizon, and other factors like supply chain issues may compound it.
What is the impact of the Quantinuum IPO on Honeywell?
The Quantinuum IPO raised $1.68 billion, and Honeywell holds an equity stake in the quantum computing company. This IPO marks up the value of Honeywell's stake, providing a positive catalyst and reinforcing its strategic pivot into quantum computing. The success of the IPO signals that the market sees value in Honeywell's investment, which can support sentiment and arguably adds to the company's intrinsic worth. While the direct financial impact on Honeywell's overall revenue is limited, it strengthens the long-term investment case and provides a tangible milestone for the company's innovation portfolio.
Why did Honeywell's aerospace division lower its 2026 growth forecast?
The aerospace division cited supply chain disruptions as the primary reason for reducing its 2026 growth outlook. These disruptions affect the company's ability to produce and deliver products, which in turn pressures margins and revenue recognition. Supply chain problems can delay orders, increase costs, and hamper the efficiency of operations. The forecast cut directly signals weaker financial performance ahead, and it weighs on both short-term and mid-term expectations. Until the supply chain stabilizes, this remains a key risk factor for Honeywell's overall results.
What does GE Aerospace's acquisition of CPP mean for Honeywell?
GE Aerospace acquired CPP, a key supplier to Honeywell, for $12 billion. This creates a competitive risk because GE Aerospace now controls a critical input in the supply chain. There is potential for GE to prioritize its own needs or leverage the supplier in ways that disadvantage Honeywell. This could lead to higher costs, supply constraints, or reduced negotiating power for Honeywell over the long term. While the impact may not be immediate, it introduces a structural uncertainty that investors should monitor.
Both worlds over time
Technical and news signals of the last 90 days on one timeline.
HON fundamental outlook?
From news analysis — different time windows than the trading horizons above
Over the next 1-7 days, HON is likely to face continued selling pressure from the S&P 100 removal, with the stock potentially testing recent lows. Watch for any announcements regarding supply chain resolutions or aerospace order updates that could trigger a bounce.
In the next 1-4 weeks, the focus will shift to earnings season and any updates on the aerospace division's growth trajectory. The Susquehanna initiation and Quantinuum IPO momentum could provide support, but supply chain issues and index exclusion may cap upside. Expect range-bound trading with a slight bearish bias.
Over the next 1-3 months, structural drivers such as AI-driven demand for Solstice chemicals and the strategic pivot to quantum computing could support a recovery. However, the competitive threat from GE Aerospace's ownership of CPP and the lingering supply chain turmoil may limit gains. The long-term outlook is cautiously bullish, contingent on successful execution of portfolio reshaping and supply chain stabilization.
What is being reported about HON
📝 Overview Generated automatically?
HON has been the subject of 15 signals across 15 articles in the last 365 days. Sentiment skews Neutral (40%).
Breakdown: 5 bullish, 4 bearish, 6 neutral. AI confidence averages 57% across all signals.
Most-cited catalysts: Quantinuum's IPO filing unlocks value for Honeywell's quantum investment (1×), Positive market reception could lift Honeywell shares (1×), Quantinuum’s upsized IPO target may boost the mark-to-market valuation of Honeywell’s stake. (1×). Most-cited risk factors: Adverse IPO market conditions could delay or reduce the offering (1×), Quantinuum's high cash burn may concern investors (1×), Quantinuum may fail to sell shares at the higher target if investor demand softens. (1×).
Related assets
Same category or comparable signal picture — each card opens the full cockpit.